These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 31522749)
1. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy. Buishand FO; Liu-Chittenden Y; Fan Y; Tirosh A; Gara SK; Patel D; Meerzaman D; Kebebew E Surgery; 2020 Jan; 167(1):224-232. PubMed ID: 31522749 [TBL] [Abstract][Full Text] [Related]
2. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma. Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525 [TBL] [Abstract][Full Text] [Related]
3. Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment. Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N Surgery; 2022 Jan; 171(1):111-118. PubMed ID: 34261605 [TBL] [Abstract][Full Text] [Related]
4. Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness. Parviainen H; Schrade A; Kiiveri S; Prunskaite-Hyyryläinen R; Haglund C; Vainio S; Wilson DB; Arola J; Heikinheimo M Pathol Res Pract; 2013 Aug; 209(8):503-9. PubMed ID: 23866946 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics. Subramanian C; Cohen MS Surgery; 2022 Jan; 171(1):119-129. PubMed ID: 34353633 [TBL] [Abstract][Full Text] [Related]
6. A novel heat shock protein 90 inhibitor potently targets adrenocortical carcinoma tumor suppression. Wang T; Subramanian C; Blagg BSJ; Cohen MS Surgery; 2020 Jan; 167(1):233-240. PubMed ID: 31561992 [TBL] [Abstract][Full Text] [Related]
7. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma. Fu Y; Sun S; Bi J; Kong C; Yin L Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence. Glover AR; Zhao JT; Ip JC; Lee JC; Robinson BG; Gill AJ; Soon PS; Sidhu SB Endocr Relat Cancer; 2015 Feb; 22(1):99-109. PubMed ID: 25595289 [TBL] [Abstract][Full Text] [Related]
9. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors. Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715 [TBL] [Abstract][Full Text] [Related]
10. Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival. Subramanian C; McCallister R; Cohen MS Surgery; 2023 Jan; 173(1):43-51. PubMed ID: 36202651 [TBL] [Abstract][Full Text] [Related]
11. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas. Ye J; Qi Y; Wang W; Sun F; Wei Q; Su T; Zhou W; Jiang Y; Yuan W; Cai J; Cui B; Ning G Endocrine; 2012 Jun; 41(3):479-86. PubMed ID: 22311173 [TBL] [Abstract][Full Text] [Related]
12. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle. Yan ZC; He L; Qiu JH; Deng WT; Lu JR; Yuan Z; Liu DJ; Zheng RQ; Jiang W Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6640-6649. PubMed ID: 30402836 [TBL] [Abstract][Full Text] [Related]
13. Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma. Subramanian C; Cohen MS Surgery; 2019 Jan; 165(1):202-210. PubMed ID: 30413320 [TBL] [Abstract][Full Text] [Related]
14. The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma. Ma C; Xiong J; Su H; Li H Int J Med Sci; 2021; 18(13):3026-3038. PubMed ID: 34220331 [No Abstract] [Full Text] [Related]
16. Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications. Sbiera I; Kircher S; Altieri B; Lenz K; Hantel C; Fassnacht M; Sbiera S; Kroiss M Front Endocrinol (Lausanne); 2021; 12():795116. PubMed ID: 34956100 [TBL] [Abstract][Full Text] [Related]
17. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors. Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma. Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721 [TBL] [Abstract][Full Text] [Related]
19. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Velázquez-Fernández D; Laurell C; Geli J; Höög A; Odeberg J; Kjellman M; Lundeberg J; Hamberger B; Nilsson P; Bäckdahl M Surgery; 2005 Dec; 138(6):1087-94. PubMed ID: 16360395 [TBL] [Abstract][Full Text] [Related]